Package Leaflet: Information for the User
Dolintol 20 mg Hard Gastro-Resistant Capsules EFG
Omeprazole
Read all of this leaflet carefully before you start taking this medicine.
Contents of the Package Leaflet
Dolintol contains the active ingredient omeprazole. It belongs to a group of medicines called “proton pump inhibitors”. These medicines work by reducing the amount of acid produced by the stomach.
Dolintol is used to treat the following conditions:
In adults:
In children:
Children over 1 year of age and = 10 kg
In children, the symptoms of the disease can include return of stomach contents to the mouth (regurgitation), vomiting and insufficient weight gain.
Children over 4 years of age and adolescents
Ulcers infected by a bacterium called Helicobacter pylori. If your child has this condition, your doctor may also prescribe antibiotics to treat the infection and allow the ulcer to heal.
Do not take Dolintol
Do not take Dolintol if you are in one of these situations. If you are not sure, talk to your doctor or pharmacist before taking Dolintol.
Warnings and precautions
Talk to your doctor or pharmacist before taking Dolintol.
Serious skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS) and acute generalized exanthematous pustulosis (AGEP) have been reported with omeprazole. Stop taking Dolintol and contact your doctor immediately if you experience any of these symptoms related to serious skin reactions described in section 4.
Dolintol may mask the symptoms of other diseases. Therefore, if you experience any of the following conditions before starting or during treatment with Dolintol, contact your doctor immediately:
If you take Dolintol for a long period (more than 1 year) your doctor will probably schedule regular check-ups. You should inform your doctor of any new or unusual symptoms or circumstances whenever you visit your doctor.
Taking a proton pump inhibitor like Dolintol, especially for a period of more than one year, may slightly increase the risk of fracture of the hip, wrist or spine. Inform your doctor if you have osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis).
If you get a rash on your skin, especially in areas exposed to the sun, you should contact your doctor as soon as possible, as it may be necessary to interrupt treatment with Dolintol. Remember to mention any other symptoms you may notice, such as joint pain.
When taking omeprazole, kidney inflammation can occur. The signs and symptoms may include decreased urine output or blood in the urine and/or hypersensitivity reactions such as fever, rash and joint stiffness. You should inform your doctor of these signs.
This medicine may affect the way your body absorbs vitamin B12, especially if you need to take it for a long time. Contact your doctor if you notice any of the following symptoms, which could indicate low levels of vitamin B12:
Children
Some children with chronic diseases may require long-term treatment, although it is not recommended. Do not give this medicine to children under 1 year of age or weighing less than 10 kg.
Other medicines and Dolintol
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription. This is because Dolintol can affect the way some medicines work and some medicines can affect Dolintol.
Do not take Dolintol if you are taking a medicine that contains nelfinavir(used to treat HIV infection).
Tell your doctor or pharmacist if you are taking any of the following medicines:
If your doctor has also prescribed the antibiotics amoxicillin and clarithromycin for you to treat ulcers caused by Helicobacter pyloriinfection, it is very important that you inform your doctor of any other medicines you are taking.
Taking Dolintol with food and drinks
See section 3.
Pregnancy, breastfeeding and fertility
If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Omeprazole passes into breast milk but it is unlikely to affect the baby when used in therapeutic doses.
Your doctor will decide whether you can take Dolintol if you are breastfeeding.
Driving and using machines
Dolintol is unlikely to affect your ability to drive or use tools or machines.
Side effects such as dizziness and visual disturbances (see section 4) may occur. If this happens, patients should not drive or use machines.
Important information about some of the ingredients of Dolintol
This medicine contains lactose and sucrose. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
This medicine contains less than 23 mg of sodium (1mmol) per capsule; this is essentially “sodium-free”.
Follow the instructions for administration of this medicine exactly as indicated by your doctor or pharmacist. If you are not sure, ask your doctor or pharmacist again.
Your doctor will tell you how many capsules to take and for how long. This will depend on your condition and age. The usual doses are indicated below.
Adults:
Treatment of symptoms of GORD, such as heartburn and acid regurgitation:
Treatment of duodenal ulcers:
Treatment of gastric ulcers:
Preventionof recurrence of stomach and duodenal ulcers:
Treatment of stomach and duodenal ulcers caused by NSAIDs
(non-steroidal anti-inflammatory drugs):
Prevention of stomach and duodenal ulcersduring NSAID therapy:
Treatment of ulcers caused by Helicobacter pylori infectionand prevention of recurrence:
Treatment of excess acid in the stomach caused by a tumour in the pancreas (Zollinger-Ellison syndrome):
Use in children and adolescents:
Treatment of symptoms of GORD, such as heartburn and acid regurgitation
Treatment of ulcers caused by Helicobacter pylori infectionand prevention of recurrence:
How to take this medicine
What to do if you or your child have problems swallowing the capsules
If you take more Dolintol than you should
If you have taken more Dolintol than your doctor prescribed, talk to your doctor or pharmacist immediately. You can also contact the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount taken.
If you forget to take Dolintol
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose. Do not take a double dose to make up for forgotten doses.
If you stop taking Dolintol
Do not stop taking Dolintol without talking to your doctor or pharmacist first.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
If you notice any of the following rare (may affect up to 1 in 1,000 people) or very rare (may affect up to 1 in 10,000 people) but serious adverse effects, stop taking omeprazole and consult your doctor immediately:
This could be "Stevens-Johnson syndrome" or "toxic epidermal necrolysis" (very rare).
Other adverse effects are:
Common Adverse Effects (may affect up to 1 in 10 people)
Uncommon Adverse Effects (may affect up to 1 in 100 people)
Rare Adverse Effects (may affect up to 1 in 1,000 people)
Very Rare Adverse Effects (may affect up to 1 in 10,000 people)
Frequency Not Known (cannot be estimated from available data)
In very rare cases, omeprazole can affect the white blood cells and cause immunodeficiency. If you have an infection with symptoms such as fever with a severely deteriorated general condition or fever with symptoms of local infection, such as neck, throat, or mouth pain, or difficulty urinating, you should consult your doctor as soon as possible to perform a blood test and rule out a lack of white blood cells (agranulocytosis). It is essential that you provide information about the medication you are taking at that time.
Reporting Adverse Effects
If you experience any adverse effects, consult your doctor or pharmacist, even if they are possible adverse effects not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Composition of Dolintol
The gelatin capsule is composed of: gelatin, indigo carmine (E-132), and quinoline yellow (E-104).
Appearance of the Product and Package Contents
Dolintol 20 mg is presented in the form of hard gelatin capsules with a green body and cap containing enteric-coated pellets.
Package sizes:
Packages containing 14, 28, or 56 capsules, and a clinical package with 500 capsules.
Only some package sizes may be marketed.
Marketing Authorization Holder
ABABOR PHARMACEUTICALS, S.L.
C/Chile 4 – Edificio 1 – 28290 LAS ROZAS (Madrid)
Spain
Manufacturer:
INDUSTRIA QUÍMICA Y FARMACÉUTICA VIR, S.A.
C/Laguna 66-68-70. Polígono Industrial Urtinsa II.
28923 Alcorcón (Madrid)
Spain
Date of the Last Revision of this Prospectus: March 2025
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/
The average price of DOLINTOL 20 mg HARD GASTRO-RESISTANT CAPSULES in October, 2025 is around 1.26 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.